IRIS
MAFFEZZOLI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.241
NA - Nord America 1.215
EU - Europa 554
SA - Sud America 178
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 4
Totale 3.295
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.167
SG - Singapore 415
IT - Italia 267
VN - Vietnam 223
CN - Cina 201
BD - Bangladesh 179
BR - Brasile 144
HK - Hong Kong 85
FR - Francia 58
DE - Germania 47
ZA - Sudafrica 42
NL - Olanda 37
GB - Regno Unito 35
IN - India 32
CA - Canada 24
IE - Irlanda 24
RU - Federazione Russa 19
AR - Argentina 17
IQ - Iraq 14
KR - Corea 14
JP - Giappone 12
MX - Messico 12
AT - Austria 11
SE - Svezia 11
MA - Marocco 10
FI - Finlandia 8
PH - Filippine 8
TR - Turchia 8
UZ - Uzbekistan 8
ES - Italia 7
ID - Indonesia 7
MY - Malesia 7
TH - Thailandia 7
CO - Colombia 6
PK - Pakistan 6
PL - Polonia 6
EC - Ecuador 5
EG - Egitto 5
KE - Kenya 5
AU - Australia 4
LT - Lituania 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
HN - Honduras 3
PY - Paraguay 3
TN - Tunisia 3
TW - Taiwan 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
DZ - Algeria 2
GR - Grecia 2
JM - Giamaica 2
PE - Perù 2
SA - Arabia Saudita 2
BB - Barbados 1
BN - Brunei Darussalam 1
CL - Cile 1
CR - Costa Rica 1
EE - Estonia 1
GT - Guatemala 1
IL - Israele 1
IR - Iran 1
KZ - Kazakistan 1
LV - Lettonia 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 3.262
Salva come PNG Salva come JPEG
Città #
Singapore 267
Ashburn 190
Dallas 176
San Jose 174
Santa Clara 90
Hong Kong 82
Council Bluffs 71
Ho Chi Minh City 69
Boardman 59
Beijing 49
Milan 45
Hanoi 42
Johannesburg 39
Hefei 35
Los Angeles 35
New York 34
Munich 25
Dublin 24
Buffalo 23
Lauterbourg 22
Parma 19
Rome 17
Marseille 16
Modena 16
São Paulo 15
Shanghai 13
Da Nang 12
Brooklyn 11
Seoul 11
Bologna 10
Orem 10
Chennai 9
Haiphong 9
Moscow 9
Paris 9
Tokyo 9
Atlanta 8
Bengaluru 8
Chicago 8
Montreal 8
Seattle 8
Columbus 7
Denver 7
Houston 7
London 7
Nuremberg 7
Portsmouth 7
Rio de Janeiro 7
Tashkent 7
Amsterdam 6
Frankfurt am Main 6
Meknes 6
Poplar 6
Turku 6
Venice 6
Vienna 6
Baghdad 5
Bangkok 5
Brescia 5
Phoenix 5
Quito 5
Stockholm 5
Bari 4
Curitiba 4
Mexico City 4
Nairobi 4
Ninh Bình 4
Sungai Petani 4
Warsaw 4
Aachen 3
Abidjan 3
Ancona 3
Bauru 3
Belo Horizonte 3
Biên Hòa 3
Boston 3
Buenos Aires 3
Cape Town 3
Düsseldorf 3
Genoa 3
Lahore 3
Ottawa 3
Paderno Dugnano 3
Perugia 3
Poços de Caldas 3
Salt Lake City 3
Scandiano 3
Thái Nguyên 3
Tianjin 3
Turin 3
Athens 2
Baku 2
Bitonto 2
Brasília 2
Brussels 2
Busto Arsizio 2
Bắc Ninh 2
Cairo 2
Can Tho 2
Caxias do Sul 2
Totale 2.025
Salva come PNG Salva come JPEG
Nome #
New hormonal agents and integrated strategies for non-metastatic, hormone-sensitive prostate carcinoma: the orphan setting?—a narrative review 188
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27 179
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors 159
The prognostic value of the haemoglobin/red cell distribution width ratio in a cohort of pre-treated patients with renal cell carcinoma receiving nivolumab 158
91 Circulating lipid profile as a prognostic factor in patients with advanced solid tumors treated with immune checkpoint inhibitors 156
Real world analysis of peritoneal metastasis from renal cell carcinoma: Meet-Uro 27 study 156
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors 140
The effect of concomitant drugs on oncological outcomes in patients treated with immunotherapy for metastatic urothelial carcinoma: a narrative review 133
External Validation of the GRade, Age, Nodes and Tumor (GRANT) Score for Patients with Surgically Treated Papillary Renal Cell Carcinoma 132
Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapy 126
Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations 121
External validation of the GRade, Age, Nodes and Tumor (GRANT) score for patients with surgically treated papillary renal cell carcinoma. - Proceedings from the Second International Urology Cancer Summit, 27th September, Portsmouth, UK. 121
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study 119
Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario 117
Takotsubo syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab plus axitinib 117
Global Variations in Oncology Professionals' Confidence Levels for Managing Antibody-Drug Conjugate Toxicities: A Cross-Continental Survey 110
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study) 109
Use of concomitant proton pump inhibitors, statins, or metformin in patients treated with pembrolizumab for advanced urothelial carcinoma: data from the ARON-2 retrospective study. 107
The distinct prognostic impact of circulating lipid profile according to neutrophil to lymphocyte ratio in patients with advanced solid tumors treated with immune check point inhibitors. 97
Prognostication for surgically treated papillary renal cell carcinoma: which model is the optimal choice? 93
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations 92
Management of oligometastatic and oligoprogressive renal cell carcinoma: an updated review 89
Immunohistochemical (IHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: secondary analyses of the Meet-URO 18 study 86
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study 78
The Role of Circulating Tumor DNA in Patients Treated with Adjuvant Immune Checkpoint Inhibitors: Clinical Reality or Distant Horizon? 75
Prognostic models for patients with metastatic urothelial carcinoma: why to use them? 73
Effectiveness and Safety of Lenvatinib and Everolimus after Immune Checkpoint Inhibitors in Metastatic Renal Cell Cancer: A Systematic Review 71
Efficacy of Enfortumab Vedotin After Platinum Chemotherapy and Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Real-World Analysis of the ARON-2EV Cohort 53
When is immunotherapy too much? The case of favorable-risk metastatic renal cell carcinoma 20
A prospective external validation of the GRade, Age, Nodes and Tumor score in the ECOG-ACRIN EA8143 PROSPER trial 11
Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 study 5
International multicenter experience of prognostic factors and treatment outcomes of metastatic non-clear cell renal cell carcinoma 4
Totale 3.295
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.635
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202361 0 0 0 0 11 2 5 1 27 0 15 0
2023/2024121 0 8 4 3 14 13 13 9 16 9 15 17
2024/2025648 7 36 44 35 69 69 38 49 55 57 59 130
2025/20262.262 154 156 328 199 249 136 160 91 242 151 244 152
2026/2027203 104 99 0 0 0 0 0 0 0 0 0 0
Totale 3.295